Benchling vs Claude
Side-by-side comparison of AI visibility scores, market position, and capabilities
Benchling is a life sciences R&D cloud platform with ~$200M+ ARR. Series E startup valued at ~$6.1B. Trusted by Pfizer, Genentech, and 1,000+ biotech/pharma teams. HQ: San Francisco.
About
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The company offers an integrated suite of tools including electronic lab notebooks (ELN), laboratory information management systems (LIMS), molecular biology design tools, and data management platforms, all connected in a unified cloud environment.
Claude 3.5 Sonnet topped coding and reasoning benchmarks in 2024; Claude 3.7 Sonnet with extended thinking launched in February 2025 as the leading model for complex professional tasks.
About
Claude is Anthropic's AI assistant, first released publicly in March 2023 and now one of the top three most-used AI assistants globally. Claude 3.5 Sonnet (June 2024) set benchmarks for coding, analysis, and instruction-following that led many developers and enterprises to migrate from GPT-4. Claude is available via claude.ai (free and Pro tiers at $20/month) and through the Anthropic API powering thousands of enterprise applications.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.